COCP

Cocrystal Pharma, Inc. is a biotechnology company focused on the discovery and development of novel antiviral therapeutics. Headquartered in Bothell, Washington, the company uses proprietary structure-based drug design technologies to create first-in-class and best-in-class antiviral drugs. Cocrystal's pipeline includes antiviral programs targeting influenza, norovirus, hepatitis C virus, and coronaviruses including SARS-CoV-2. The company's technology platform enables the design of inhibitors that target viral replication mechanisms.